✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
首页 › 产品目录 › 2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1)

2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1)

CAS 120066-54-8C17H29GdN4O7MW 558.7

2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1)(CAS 120066-54-8):分子式 C17H29GdN4O7、分子量 558.7。

产品概览

CAS号120066-54-8
分子式C17H29GdN4O7
分子量558.7
熔点>225 °C
应用领域Uses: MEDICATION、Contrast Media、Injectable contrast Medium for Magnetic Resonance Imaging (MRI)、Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues.、Contrast agents、Use (kg、approx.) in Germany (2009): >500、Consumption (g per capita、approx.) in Germany (2009): 0.00611、Calculated removal (%): 22、Methods of Manufacturing: Preparation: M. F. Tweedle et al、European Patent Office patent 292689、eidem、United States of America patent 4885363 (1988、1989、both to Squibb).、Formulations、Preparations: ProHance (Gadoteridol) Injection is a clear、colorless to slightly yellow solution containing 279.3 mg、mL of gadoteridol in rubber stoppered vials.

应用领域

登记用途:Uses: MEDICATION、Contrast Media、Injectable contrast Medium for Magnetic Resonance Imaging (MRI)、Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues.、Contrast agents、Use (kg、approx.) in Germany (2009): >500、Consumption (g per capita、approx.) in Germany (2009): 0.00611、Calculated removal (%): 22、Methods of Manufacturing: Preparation: M. F. Tweedle et al、European Patent Office patent 292689、eidem、United States of America patent 4885363 (1988、1989、both to Squibb).、Formulations、Preparations: ProHance (Gadoteridol) Injection is a clear、colorless to slightly yellow solution containing 279.3 mg、mL of gadoteridol in rubber stoppered vials.。

技术档案

这个产品是什么

2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1) 是一种化工化合物,登记 CAS 号为 120066-54-8,分子式 C17H29GdN4O7(分子量 558.7)。

识别信息

登记 CAS 号:120066-54-8

其分子式 C17H29GdN4O7 由 17 个碳、29 个氢、1 个钆、4 个氮、7 个氧 组成。

别名/同义词:2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1) · gadolinium 2,2',2''-[10-(carboxymethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate - 1-deoxy-1-(methylamino)-D-glucitol (1:1) · Gadoteridol

常见问题

2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1) 的 CAS 号是多少?

2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1) 的 CAS 登记号为 120066-54-8。

2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1) 的分子式与分子量是多少?

分子式 C17H29GdN4O7,分子量 558.7。

2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1) 还有哪些别名?

别名/同义词:2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1)、gadolinium 2,2',2''-[10-(carboxymethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate - 1-deoxy-1-(methylamino)-D-glucitol (1:1)、Gadoteridol。

2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1) 的登记用途是什么?

登记用途:Uses: MEDICATION、Contrast Media、Injectable contrast Medium for Magnetic Resonance Imaging (MRI)、Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues.、Contrast agents、Use (kg、approx.) in Germany (2009): >500、Consumption (g per capita、approx.) in Germany (2009): 0.00611、Calculated removal (%): 22、Methods of Manufacturing: Preparation: M. F. Tweedle et al、European Patent Office patent 292689、eidem、United States of America patent 4885363 (1988、1989、both to Squibb).、Formulations、Preparations: ProHance (Gadoteridol) Injection is a clear、colorless to slightly yellow solution containing 279.3 mg、mL of gadoteridol in rubber stoppered vials.。

PubChem 公开数据

2,2',2''-[10-(羧甲基)-1,4,7,10-四氮杂环十二烷-1,4,7-三基]三乙酸钆 - 1-脱氧-1-(甲氨基)-D-山梨糖醇 (1:1)(CAS 120066-54-8)的独立参考数据,整理自公开化学数据库。

各数据库的登记标识

CAS Registry Number120066-54-8
PubChem CID60714
Molecular formulaC17H29GdN4O7
IUPAC name2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
UNII (FDA)0199MV609F

计算分子描述符

Molecular Weight558.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count11
Rotatable Bond Count5
Exact Mass559.12774
Monoisotopic Mass559.12774
Topological Polar Surface Area154
Heavy Atom Count29

在册的理化数值

Melting Point>225 °C
SolubilityIn water, 737 mg/mL

在册的记载用途

    Injectable contrast Medium for Magnetic Resonance Imaging (MRI)Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues. /Contrast agents/

    同义词与商品名

    GADOTERIDOL; ProHance; 120066-54-8; Gadolinium-HP-DO3A; Prohance Multipack; DTXSID2048662; GD-HP-DO 3A; SQ-32692; Gd-HPDO3A; Gd-HP-DO3A; Gadolinium-HP-Do 3A; DTXCID5028588; 0199MV609F; NSC-760055; HSDB 7549; SQ 32,692

    公开数据库对它的描述

    Gadoteridol · CAS 120066-54-8 · C17H29GdN4O7. UNII 0199MV609F. Melting Point: >225 °C; Solubility: In water, 737 mg/mL.

    物理形态与操作说明

    数据来源:PubChem / Wikidata;与随货 COA 不一致时以 COA 为准。

获取报价

✉ info@591daili.com☎ +86-18553102138📞 WhatsApp邮件询价WhatsApp 询价

供应商:济南圣和化工有限公司

English page: gadolinium 2,2',2''-[10-(carboxymethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate - 1-deoxy-1-(methylamino)-D-glucitol (1:1)

鲁ICP备19031700号-2